A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

Clinical trial NCT01611272 · COMPLETED

Trial details

NCT number: NCT01611272
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Coronary Syndromes

Start date: 2013-04-30
Primary completion: 2016-07-20
Enrollment: 3402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.